Comparative evaluation of empagliflozin, canagliflozin and sitagliptin cardioprotective properties in rats with experimental type 2 diabetes mellitus

por A. V. Simanenkova, S. M. Minasian, T. L. Karonova, T. D. Vlasov, N. V. Timkina, А. K. Khalzova, O. S. Fuks, A. A. Shimshilashvili, V. A. Timofeeva, Yu. Yu. Borshchev, M. M. Galagudza
Publicado 2021